Latest news
The prostate cancer treatment a famous presenter chose cuts the risk of side effects, and it is already available where most men are not offered it - OkDiarioOkDiario · Fri, 07 Aug 2026 23:00:00 GMTRadiopharmaceutical may benefit patients with metastatic prostate cancer sooner - Medical XpressMedical Xpress · Fri, 07 Aug 2026 17:20:05 GMTRadiopharmaceutical could benefit metastatic prostate cancer patients sooner - Bioengineer.orgBioengineer.org · Fri, 07 Aug 2026 02:58:49 GMTFDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 00:45:35 GMTTargeted therapy combinations may overcome treatment resistance in advanced prostate cancer - Bioengineer.orgBioengineer.org · Tue, 04 Aug 2026 01:08:10 GMTCombination of targeted therapies could help overcome treatment resistance in advanced prostate cancer - UCLA HealthUCLA Health · Mon, 03 Aug 2026 17:14:14 GMTCreating a 3D map of enhancer networks in prostate cancer could lead to targeted therapies - BioTechniquesBioTechniques · Thu, 30 Jul 2026 07:00:00 GMTICR welcomes FDA approval of capivasertib for advanced prostate cancer - The Institute of Cancer Research (ICR)The Institute of Cancer Research (ICR) · Tue, 28 Jul 2026 10:33:25 GMT